If that happens, then way is open to Fib 38, IMO, down around $26. Depending on earnings, could rebound test its 200 dmas about $25, but IMO the buyback program should offer some support at that level.
Market clearly worried about size of miss on Lipitor. Management set the bar too high. That was dumb.